February 04, 2020 – Milan, Italy and Morristown, NJ – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of
Milan, Italy and Morristown, NJ, USA, January 9, 2020 - Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of
The information on the following pages may be made available in the United States. By clicking on the link below, you agree that you are in the United States.
